Sofosbuvir / Velpatasvir
Also known as: Epclusa, Sofosbuvir-Velpatasvir.
Wholesale (NADAC) cost for every strength and dosage form — the price pharmacies pay, published weekly by CMS. Not your out-of-pocket price.
Wholesale (NADAC) prices — every strength & form
| Strength | Form | NADAC / unit | Class |
|---|---|---|---|
| 400 MG-100 MG | Tablet | $865.96 / unit | Brand |
| 400-100 | (unspecified) | $278.25 / unit | Generic |
Wholesale (NADAC) — the price pharmacies pay, not your out-of-pocket price. Brand list prices fall after confidential rebates.
NADAC week of 2026-07-01 · updated weekly · source CMS
Medicaid & Medicare spending · 2024
In 2024, Medicaid paid $481,929,150 gross for Sofosbuvir / Velpatasvir across 53,018 prescriptions (measured, national).
Medicare Part D EST spent an estimated ~$108,534,492 gross (retail pharmacy only; excludes Part B).
Gross program spending, before rebates — not what patients pay out of pocket. Brand net cost is materially lower after confidential rebates; generics are close to net.
Source: Medicaid SDUD 2024 · Medicare Part D 2024 · CMS